<p>Pharmaron Beijing Co. Ltd. has announced the placing of 58,440,762 new H shares under its general issuance mandate. The company has entered into a placing agreement with appointed placing agents, who will use their best efforts to procure subscribers for the new shares. The placing is not registered in the United States and does not constitute a public offering there. An application will be made for the listing and permission to deal in the new shares on the Hong Kong Stock Exchange. Completion of the placing is subject to certain conditions and may or may not proceed, so shareholders and potential investors are advised to exercise caution. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmaron Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260115-11991268), on January 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

300759

Pharmaron Beijing Announces Private Placement of 58 Million New H Shares